CTLA4 and B-cell chronic lymphocytic leukemia: T cells from CLL patients are characterized by an increased expression of PD-L1, cytotoxic T-lymphocyte-associated protein-4 (CTLA-4), and other co-inhibitory receptors, exhibiting an exhausted phenotype (10, 11).